International Stem Cell CORP (ISCO) › Capital ExpendituresInternational Stem Cell CORP (ISCO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $167.0K2014: $290.0K2015: $35.0K2016: $231.0K2017: $112.0K2018: $185.0K2019: $164.0K2020: $28.0K2021: $23.0K2022: $1.0K2023: $80.0K2024: $166.0K2025: $43.0K$43.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$43.0K-74.1%2024$166.0K+107.5%2023$80.0K+7900.0%2022$1.0K-95.7%2021$23.0K-17.9%2020$28.0K-82.9%2019$164.0K-11.4%2018$185.0K+65.2%2017$112.0K-51.5%2016$231.0K+560.0%2015$35.0K-87.9%2014$290.0K+73.7%2013$167.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share